Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

84.4K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
84.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

41
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
41

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rising Prevalence of Mild Chronic Gastritis in Children: A Single Center Experience.

Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·2024
Same author

Chronic Diarrhea in an Infant With Malrotation: A Diagnostic Dilemma.

JPGN reports·2023
Same author

Renal-hepatic-pancreatic dysplasia type 2: Perinatal lethal condition or a multisystemic disorder with variable expressivity.

Molecular genetics & genomic medicine·2023
Same author

Plasma Biomarkers and Fractional Exhaled Nitric Oxide in the Diagnosis of Eosinophilic Esophagitis.

Journal of pediatric gastroenterology and nutrition·2022
Same author

Sodium Bicarbonate Locks May Be a Safe and Effective Alternative in Pediatric Intestinal Failure: A Pilot Study.

Journal of pediatric gastroenterology and nutrition·2022
Same author

Recognizing a MIS-Chievous Cause of Acute Viral Gastroenteritis.

Frontiers in pediatrics·2021

Related Experiment Video

Updated: Oct 26, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.5K

Pediatric intestinal failure and the microbiome.

Rohit Josyabhatla1, Essam M Imseis1

  • 1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center at Houston, TX, USA.

Seminars in Perinatology
|August 1, 2021
PubMed
Summary

Neonatal intestinal failure involves microbiome changes and complications. Modulating the gut microbiome offers a promising therapeutic approach for this condition.

Keywords:
AntibioticsGut microbiotaIntestinal failureMicrobiomeParenteral lipidProbioticsShort Bowel Syndrome

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.1K

Related Experiment Videos

Last Updated: Oct 26, 2025

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
06:51

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model

Published on: July 28, 2023

1.5K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.1K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.1K

Area of Science:

  • Gastroenterology
  • Microbiology
  • Neonatal Medicine

Background:

  • Neonatal intestinal failure (NIF) is a critical condition requiring long-term parenteral nutrition.
  • NIF is characterized by significant alterations in the gut microbiome compared to healthy infants.
  • The impact of this dysbiotic microbiome on NIF complications is an emerging area of research.

Purpose of the Study:

  • To explore the relationship between the dysbiotic microbiome and complications in neonatal intestinal failure.
  • To investigate the potential of microbiome modulation as a therapeutic strategy for NIF.

Main Methods:

  • Comparative analysis of microbiome composition in NIF patients versus healthy controls.
  • Review of current literature on the effects of enteral/parenteral nutrients and probiotics on the NIF microbiome.

Main Results:

  • Significant differences in microbial diversity and composition were observed in infants with NIF.
  • Early evidence suggests that targeted nutritional and probiotic interventions may influence the microbiome in NIF.

Conclusions:

  • The altered microbiome in neonatal intestinal failure plays a role in disease complications.
  • Modulating the gut microbiome through nutritional and probiotic therapies presents a promising avenue for improving outcomes in NIF.